Medtronic Plc, founded in 1949 and headquartered in Dublin, Ireland, is a global leader in medical technology, offering innovative healthcare solutions aimed at alleviating pain, restoring health, and extending life. The company specializes in developing and manufacturing a wide array of medical devices and therapies for various chronic diseases, including diabetes management products, cardiovascular devices, and surgical equipment.
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Medtronic has been active in the bond market since the 1990s, issuing various debt instruments to finance acquisitions and operations. Notably, the company issued a significant $6 billion bond in 2021 to support its acquisition of Mazor Robotics, demonstrating its strategy of growth through innovation. Currently, Medtronic's bonds yield around 3.5%, which is competitive within the healthcare sector, reflecting strong credit ratings and investor confidence despite market fluctuations. Additionally, the company's bonds have features such as call provisions, allowing for potential refinancing opportunities if market conditions are favorable.